For Biopharma

Education & events

News & Updates

Poster - 20 October 2024

Receptor occupancy assay development challenges for rare targets of bispecific drugs

Poster - 28 July 2024

Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials

Info Sheet - 16 July 2024

Global Trial Connect Brochure

Poster - 19 May 2024

Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists

Recent

Posters and publications

Poster - 17 November 2024

Inhaled delivery of a selective immune modulator to minipigs produces favorable toxicity profile

Poster - 17 November 2024

Mouse versus rabbit: Time course of corneal ocular toxicity of an antibody drug conjugate (ADC) with a maytansinoid payload

Poster - 17 November 2024

Retrospective analysis of nonclinical regulatory strategy for 13 approved oncology antibody-drug conjugates

Poster - 17 November 2024

Evaluation of endogenous and ex vivo stimulated matrices for validation of cytokine expression assessment

Poster - 17 November 2024

A 29-day two-dose and 3-day one-dose research and development study of intrathecal injection or epidural infusion in rats

Upcoming

Conferences & events

Recorded

Videos & Webinars

Webinar - 15 May 2024

Overcoming key challenges in global cell and gene therapy trials with Labcorp

Video - 25 April 2024

From Lab to Life: Unraveling the mysteries of nonclinical ADME and human AME (Insights for optimizing your hAME)

Video - 8 April 2024

Challenges and opportunities for bioanalytical support of new drug modalities

Trending

Scientific Topics

Info Sheet - 23 July 2024

Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability

Info Sheet - 23 July 2024

Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services

Article - 14 May 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)

Info Sheet - 2 May 2024

Labcorp Biopharma Laboratory Services: Antibody-drug conjugate (ADC) capabilities

Article - 8 April 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials

Article - 8 April 2024

Navigating complexities in ADC development with specialized global laboratory support and scientific expertise

Article - 7 December 2023

OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial

Article - 6 December 2023

Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Article - 28 September 2023

Cell therapy for treatment of cancer

Managing Your Health

Diseases & Therapeutic Areas

Treatment Modalities & Methods

Scientific Lab Disciplines

Labs

Industries

Education & events

Receptor occupancy assay development challenges for rare targets of bispecific drugs

Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials

Global Trial Connect Brochure

Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists

Posters and publications

Inhaled delivery of a selective immune modulator to minipigs produces favorable toxicity profile

Mouse versus rabbit: Time course of corneal ocular toxicity of an antibody drug conjugate (ADC) with a maytansinoid payload

Retrospective analysis of nonclinical regulatory strategy for 13 approved oncology antibody-drug conjugates

Evaluation of endogenous and ex vivo stimulated matrices for validation of cytokine expression assessment

A 29-day two-dose and 3-day one-dose research and development study of intrathecal injection or epidural infusion in rats

Conferences & events

Videos & Webinars

Overcoming key challenges in global cell and gene therapy trials with Labcorp

From Lab to Life: Unraveling the mysteries of nonclinical ADME and human AME (Insights for optimizing your hAME)

Challenges and opportunities for bioanalytical support of new drug modalities

Scientific Topics

Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability

Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)

Labcorp Biopharma Laboratory Services: Antibody-drug conjugate (ADC) capabilities

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials

Navigating complexities in ADC development with specialized global laboratory support and scientific expertise

OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial

Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Cell therapy for treatment of cancer